Skip to Content

WARRICK 1621 (Griseofulvin (ultramicrocrystalline) 250 mg)

Pill imprint WARRICK 1621 has been identified as Griseofulvin (ultramicrocrystalline) 250 mg.

Griseofulvin is used in the treatment of dermatophytosis; onychomycosis, toenail; tinea capitis; tinea barbae; onychomycosis, fingernail (and more), and belongs to the drug class miscellaneous antifungals. Risk cannot be ruled out during pregnancy. Griseofulvin 250 mg is not a controlled substance under the Controlled Substance Act (CSA).

Griseofulvin (ultramicrocrystalline) 250 mg WARRICK 1621
Discount Card Promo
Griseofulvin (ultramicrocrystalline)
Imprint:
WARRICK 1621
Strength:
250 mg
Color:
White
Shape:
Round
Availability:
Prescription only
Drug Class:
Miscellaneous antifungals
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Manufacturer:
ESI Lederle Generics

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide